Thus far in February 2025, the stock surged 15% after the company registered a 10.5% YoY growth in exports in January 2025 on the back of stable demand for its products in the overseas markets.
According to CEO Srikrishna Ramakarthikeyan, the re-listing of the mid-tier IT company will not change its focus or business ...
Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...
51m
ABS-CBN on MSNGlobe still keen on GCash IPO in Philippines but eyes smaller public float than required in stock marketGlobe Telecom is still keen on a Philippine IPO for GCash but wants to public float smaller than the 20 percent required by the PSE and SEC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results